Nevertheless, our data did show a higher percentage of radiographic tumor regression in patients with wild-type TP53. Jiang et al. reported that TP53 alterations predicted worse OS in HNSCC patients receiving immunotherapy61. The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.